November 3, 2025 Akeso / biopharmaceutical / cancer research / China News / healthcare innovation / immuno-oncology / Industry / ivonescimab / Phase III trials / TNBC Akeso’s Ivonescimab Reaches Fourth Breakthrough in China for Triple-Negative Breast Cancer Source: ChinaMoneyNetwork.com Continue